Print version of this report
Type of Product Medical Device
TGA Recall Reference RC-2017-RN-00319-1
Product Name/Description LipiFlow System Activator
(used as part of the LipiFlow Thermal Pulsation System)

Model Number: LFD-1000

All Lots distributed between 1 Jan 2014 to 3 Feb 2017

Expiry Date: Jul 2017 to Feb 2021

ARTG Number: 189438
Recall Action Level Hospital
Recall Action Classification Class III
Recall Action Commencement Date 7/03/2017
Responsible Entity Emergo Asia Pacific Pty Ltd T/a Emergo Australia
Reason/Issue There is a labelling issue with specific lots of the LipiFlow System Activator. The Activator package label, box label, package insert and the Lipiflow System Instructions for Use (IFU) specify 10°C to 40°C for the Activator storage temperature. This specification was with the intent that the Activator would be stored in a temperature-controlled room environment (with heat and air conditioning) with allowance for occasional fluctuations between 10°C and 40°C.
Upon review, it has been determined that the labelled storage temperature should be consistent with the temperature conditions tested for the entire duration of the product shelf-life. Accordingly, the storage temperature on the Activator package and box labels has been revised to specify, “Store at controlled room temperature.” The revised package insert and the Lipiflow System IFU specify: “Store the Activator at controlled room temperature (20°C to 25°C) with short-term (< 72 hours) excursions permitted between 5°C and 38°C.”
Recall Action Recall for Product Correction
Recall Action Instructions Emergo is requesting customers to read the enclosed "Summary of Important Labelling Changes for the LipiFlow System" and discontinue use of stock that are not in temperature-controlled environments (without heat and air conditioning). Customers are further requested to contact their local distributor to organise for replacement stock. This action has been closed-out on 23/06/2017.
Contact Information 02 9006 1662 - Emergo